Accueil
Explorer
nav.journalClub
Tendances
Plus
synapse
⌘+K
Langue
Français
Français
Genetic Predictors of Hematopoietic Cell Transplantation Outcomes in Patients with Myelofibrosis | Synapse
March 3, 2026
Genetic Predictors of Hematopoietic Cell Transplantation Outcomes in Patients with Myelofibrosis
MR
Maryam Rafati
National Cancer Institute
FP
Filip Pirsl
National Institutes of Health
HK
Hormuzd A. Katki
American Cancer Society
See all
Key Points
Outcomes are significantly influenced by specific genetic predictors in patients with myelofibrosis.
Key evidence shows that the presence of specific biomarkers correlates with improved post-transplant outcomes.
Observational analysis of genetic profiles among myelofibrosis patients undergoing hematopoietic cell transplantation reveals notable insights.
Identifying genetic predictors may lead to more tailored treatment strategies, enhancing patient care.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Rafati et al. (Sun,) studied this question.
synapsesocial.com/papers/69a76011c6e9836116a2c79c
https://doi.org/https://doi.org/10.1016/j.jtct.2025.12.087